Otago Virologist Dr Jemma Geoghegan Wins 2027 Fleming Prize for Pandemic Genomics Work

"We can't always predict which discoveries will turn out to be useful, or when."
Geoghegan on why years of virus-evolution research proved vital during Covid-19.
Mark

Why does this prize matter beyond Otago?

Mimi

It recognises work that put genome sequencing at the centre of outbreak investigations during Covid, and that programme was later called world leading.

Mark

What did the sequencing actually do?

Mimi

It identified transmission pathways, resolved outbreak clusters and guided interventions, using real-time genomic data.

Luke

"World leading" is a label the article reports without saying who applied it. It's attributed, not independently shown here.

Mark

Fair. What's her own framing of the success?

Mimi

That years of basic research into virus evolution were applied directly to transmission. She says you can't always predict which discoveries will prove useful, or when.

Luke

Worth noting she was part of a team that established the programme. The article doesn't say what her specific role was.

Mark

And where is her work going now?

Mimi

Pathogen genomics across human, wildlife and environmental systems, to help prepare for the next pandemic.

Luke

The article doesn't say what that preparation looks like in practice, or what results exist so far.

Mark

What comes next?

Mimi

She'll receive the prize and give the Fleming Prize Lecture at the society's conference in Birmingham next year.

  • A University of Otago virologist has been named winner of the Microbiology Society's 2027 Fleming Prize, one of the field's highest honours.
  • Dr Jemma Geoghegan helped build New Zealand's SARS-CoV-2 genomic surveillance programme in 2020, when the country needed to track the virus fast.
  • Viral sequencing became central to outbreak investigations, revealing how the virus moved between people and where clusters were forming.
  • Her years of basic research on virus evolution were turned directly toward the urgent demands of Covid-19 response.
  • The prize will be presented in Birmingham next year, where she will give the Fleming Prize Lecture, and her work now turns to pathogen genomics to prepare for the next pandemic.

In a quiet corner of Otago, a virologist whose career has traced the unseen forces shaping infection has been named the recipient of the 2027 Fleming Prize, one of microbiology's most esteemed honours. Dr Jemma Geoghegan's path, from patient study of how viruses and their hosts evolve together to the front lines of a global pandemic, shows how long-held curiosity can later become essential public knowledge. Her recognition honours both the discoveries that came before and the genomic work that helped New Zealand understand a virus in real time. It also reminds us that the sciences most needed in a crisis are often built slowly, long before anyone knows they will be needed.

A researcher in Otago's Department of Microbiology and Immunology has been awarded the 2027 Fleming Prize, one of the highest honours in microbiology. Dr Jemma Geoghegan, who holds the Webster Family Chair in Viral Pathogenesis and is a Rutherford Discovery Fellow, is recognised for work that has traced the hidden forces shaping infectious disease.

Her research, spanning virology, evolutionary biology and genomics, has described thousands of viruses and challenged long-held assumptions about how viruses and their hosts relate. When Covid-19 arrived, that foundation placed her close to the front line. In 2020 she helped establish New Zealand's SARS-CoV-2 genomic surveillance programme, which made viral sequencing central to tracing transmission, resolving clusters and guiding interventions.

Geoghegan credits the long lead time behind that effort: "We can't always predict which discoveries will turn out to be useful, or when." Her public engagement, recognised with the 2025 Prime Minister's Science Communication Prize, reflects her belief that science matters most when it touches people's lives.

Her work now widens into pathogen genomics across human, wildlife and environmental systems, aiming to prepare for the next pandemic. On receiving the honour, she thanked the students, postdocs and collaborators who shared the work, saying that science is very much a collective effort. The prize will be presented at the society's conference in Birmingham next year, where she will also deliver the Fleming Prize Lecture.

A researcher in Otago's Department of Microbiology and Immunology has been awarded the 2027 Fleming Prize, one of the highest honours in microbiology. Dr Jemma Geoghegan, who holds the Webster Family Chair in Viral Pathogenesis and is a Rutherford Discovery Fellow, receives the prize from the Microbiology Society for work that has traced the hidden forces shaping infectious disease.

Geoghegan's research sits where virology, evolutionary biology and genomics meet. She has discovered and described thousands of viruses, and her findings have challenged long-held assumptions about how viruses and their hosts relate to one another. That grounding in basic evolutionary science put her close to the front line when Covid-19 arrived.

In 2020, she was part of the team that established New Zealand's SARS-CoV-2 genomic surveillance programme. The programme helped make viral genome sequencing central to outbreak investigations. It was later described as "world leading". It showed how genomic data gathered in real time could shape public health decisions: identifying how the virus was moving between people, resolving clusters of cases, and guiding interventions.

Geoghegan has pointed to the long lead time behind that effort. "We can't always predict which discoveries will turn out to be useful, or when," she said. By her account, approaches developed over years of research into virus evolution were applied directly during Covid to understand transmission and inform New Zealand's response.

The pandemic also made her a trusted expert voice on infectious diseases. Her public engagement was recognised with the 2025 Prime Minister's Science Communication Prize. She says communicating science matters, "particularly when you're working on something that directly affects people's lives", and that it is a part of the job she greatly enjoys.

Her current work is widening. She is now researching pathogen genomics across human, wildlife and environmental systems, with the aim of helping prepare for the next pandemic.

On receiving the prize, Geoghegan thanked the students, postdocs and collaborators she has worked with in New Zealand and overseas. "Science is very much a collective effort," she said, adding that she has been fortunate to work with people who contributed enormously to the research being recognised.

The Fleming Prize is named after Sir Alexander Fleming, a pioneer of modern medicine, and the Microbiology Society awards it annually to someone with an outstanding research record. It will be presented at the society's annual conference in Birmingham in the United Kingdom next year, where Geoghegan will also deliver the Fleming Prize Lecture.

Science is very much a collective effort, and I've been fortunate to work with some fantastic people.
— Dr Jemma Geoghegan
We can't always predict which discoveries will turn out to be useful, or when.
— Dr Jemma Geoghegan
Quieres la nota completa? Lee el original en ODT ↗
Contáctanos FAQ